All In MedTech

FDA Clearance Tracker · P150038-S025

Exablate Model 400 Type 1.0 & Type 1.1 (Exablate Neuro)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 12, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 12, 2023

Approved

Time to decision

267 days

Received Jan 18, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150038-S025
Device name
Exablate Model 400 Type 1.0 & Type 1.1 (Exablate Neuro)
Applicant
Insightec
Applicant location
Tirat Carmel
Received
Jan 18, 2023
Decided
Oct 12, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150038

Device type

Device class
Class III

Every decision under product code POH

FDA's approval statement

As written in FDA's record.

approval for a new software version 9.0 and hardware changes for the Exablate Model 4000 Type 1.1 System

Source documents

Other decisions for Insightec

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.